Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
nearly every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community
-
of scientific publications in relevant fields. Experience with models of myopathies or inflammation. Familiarity with stem cell-derived muscle models or 3D culture systems (including physiological
-
Preferred Qualifications: Experience as a Clinical Nurse Practitioner or Physician Assistant Prior clinical experience in Hematology-Oncology or Stem Cell Transplant Advanced Cardiac Life Support (ACLS
-
release of cell therapy products. At UCI, the cGMP facility will enable clinical trials of cell therapeutics, including stem cell populations and bone marrow transplantation, as well as Chimeric Antigen
-
nearly every area of health. We are home to five Nobel laureates who have advanced the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community
-
induced pluripotent stem cells (iPSCs); differentiation of pluripotent cells into neuronal lineages; genome engineering using CRISPR/Cas9; molecular biology and biochemistry laboratory techniques (e.g
-
the understanding of cancer, neurodegenerative diseases, aging and stem cells. Pride Values UCSF is a diverse community made of people with many skills and talents. We seek candidates whose work experience or
-
stem cells (satellite cells) can be guided by anatomical and environmental signals to generate muscle fibers that are more resistant to disease. Using a unique collection of genetically engineered
-
pathology related to stem cell transplant and immunotherapy. Positive factors for consideration include, but are not limited to: Demonstrable interest and expertise in genomics and precision oncology
-
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt | Stein bei N rnberg, Bayern | Germany | 2 months ago
applications, improving lives. Recently, our Gene Editing group at the Institute of Stem Cell Research developed Synthetic Transfer Vehicles (STVs), a programmable protein-based RNA delivery platform